Abstract
Many viruses, including retroviruses, are characterized by their specific cell tropism1–3. Lymphadenopathy-associated virus (LAV) is a human lymphotropic retrovirus isolated from patients with acquired immune deficiency syndrome (AIDS) or related syndromes4,5, that displays selective tropism for a subset of T lymphocytes defined by the expression of a surface glycoprotein of relative molecular mass 62,000 (62K) termed T4 (refs 6–8). This glycoprotein delineates a subset of T lymphocytes with mainly helper/inducer functions, while T lymphocytes of the reciprocal subset express a glycoprotein termed T8, have mainly cytotoxic/suppressor activities, and are unable to replicate LAV7,9. Such a tropism may be controlled at the genomic level by regulatory sequences, as described for the human T-cell leukaemia viruses HTLV-I and -II (refs 2,3). Alternatively or concomitantly, productive cell infection may be controlled at the membrane level, requiring the interaction of a specific cellular receptor with the virus envelope, as demonstrated recently for Epstein–Barr virus (EBV)1. Therefore, we have investigated whether the T4 molecule itself is related to the receptor for LAV. We report here that preincubation of T4+ lymphocytes with three individual monoclonal antibodies directed at the T4 glycoprotein blocked cell infection by LAV. This blocking effect was specific, as other monoclonal antibodies—such as antibody to histocompatibility locus antigen (HLA) class II or anti-T-cell natural killer (TNK) target—directed at other surface structures strongly expressed on activated cultured T4+ cells, did not prevent LAV infection. Direct virus neutralization by monoclonal antibodies was also ruled out. These results strongly support the view that a surface molecule directly involved in cellular functions acts as, or is related to, the receptor for a human retrovirus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fingeroth, J. D. et al. Proc. natn. Acad. Sci. U.S.A. 81, 4510–4514 (1984).
Leuz, J. et al. Nature 308, 467–470 (1984).
Chen, I. S., McLaughlin, J. & Golden, D. W. Nature 309, 276–279 (1984).
Barre Sinoussi, F. et al. Science 220, 868–871 (1983).
Vilmer, E. et al. Lancet i, 753–756 (1984).
Klatzmann, D. et al. Ann. N.Y. Acad. Sci. (in the press).
Klatzmann, D. et al. Science 225, 59–63 (1984).
Reinherz, E. L. et al. Proc. natn. Acad. Sci. U.S.A. 76, 4061–4065 (1979).
Reinherz, E. L. & Schlossman, S. F. Cell 19, 821–827 (1980).
Charron, D. J. & McDewitt, M. O. J. exp. Med. 152, 18s–36s (1980).
Hercend, T. Eur. J. Immun. 14, 844–852 (1984).
Engleman, E. G. et al. J. Immun. 130, 2623–2628 (1983).
Dalgleish, A. et al. Nature 312, 763–767 (1984).
Gallo, R. C. et al. Science 224, 500–504 (1984).
Montagnier, L. et al. Science 225, 63–66 (1984).
Meuer, S. C., Schlossman, S. F. & Reinherz, E. L. Proc. natn. Acad. Sci. U.S.A. 79, 4395–4399 (1982).
Biddison, W. E. et al. J. exp. Med. 159, 783–797 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klatzmann, D., Champagne, E., Chamaret, S. et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767–768 (1984). https://doi.org/10.1038/312767a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/312767a0
This article is cited by
-
Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
Gene Therapy (2021)
-
Efficient functional screening of a cellular cDNA library to identify severe fever with thrombocytopenia syndrome virus entry factors
Scientific Reports (2020)
-
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Frontiers of Medicine (2020)
-
Optimal homotopy analysis of a chaotic HIV-1 model incorporating AIDS-related cancer cells
Numerical Algorithms (2018)
-
Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein
Virology Journal (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.